3002150010
Anti-cancer drug preparation
Including the first and second batches of related products on the list of anti-cancer drugsDeclaration Elements
0: Brand type
1: Export benefits situation
2: Purpose:
3: Processing technology
4: Is the dosage prescribed
5: Is it retail packaging
6: Has this batch been approved for registration and listing in China
7: Ingredients
8: Source:
9: Brand (Chinese or foreign name)
10: Model number
11: Packaging specifications
12:GTIN
13:CAS
14: Other
Customs Control Code
Customs Clearance Voucher for Entry Goods
Customs Clearance Voucher for Exit Goods
CIQ Category Code
Entry Animal and Plant, Animal and Plant Products Quarantine
Exit Animal and Plant, Animal and Plant Products Quarantine
On behalf of Entry Health Quarantine(或：Agent for Entry Health Quarantine)
On behalf of Exit Health Quarantine(或：Agent for Exit Health Quarantine)
By each trade agreement
RCEP
Directory
ChinaChina HS CodeSection 6Products of the chemical industry and related industries30medicine3002Human blood; Animal blood products used for disease treatment, prevention or diagnosis; Anti serum, other blood samples, and immune products, whether modified or processed through biological processes; Vaccines, toxins, cultured microorganisms (excluding yeast) and similar products; Cell cultures, whether modified or not300215Immune products, already formulated in dosage or made into retail packaging30021500Immune products, already formulated in dosage or made into retail packaging3002150010Anti-cancer drug preparationCIQ
Anti cancer drug preparations (excluding cancer adjuvant therapy drugs) (including the first and second batches of related products on the anti-cancer drug list) (other chemical products)
Anti cancer drug preparations (excluding cancer adjuvant therapy drugs) (including the first and second batches of related products on the anti-cancer drug list) (biological products)
Disclaimer
The data on this page is sourced from publicly available information and is for reference only. It has no legal effect. Actual procedures should be based on the latest Import and Export Tariff Schedule and relevant laws and regulations issued by the General Administration of Customs.
